Market Outlook
The global Bioresorbable Medical Material market size was valued at USD 1450.9 million in 2022 and is forecast to a readjusted size of USD 2635.4 million by 2029 with a CAGR of 8.9% during review period.
The bioresorbable medical material in this report contains polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL) and PLGA. Global Bioresorbable Medical Material key players include Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, etc. Global top five manufacturers hold a share over 50%.
USA is the largest market, with a share over 40%, followed by Europe and China, both have a share over 35% percent. In terms of product, PLA is the largest segment, with a share over 20%. And in terms of application, the largest application is Orthopedics, followed by Drug Delivery.
This report is a detailed and comprehensive analysis for global Bioresorbable Medical Material market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Bioresorbable Medical Material market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Bioresorbable Medical Material market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Bioresorbable Medical Material market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Bioresorbable Medical Material market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bioresorbable Medical Material
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bioresorbable Medical Material market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Evonik
Corbion
DSM
Mitsui Chemicals
PCAS
Poly-Med
KLS Martin
Segmentation By Type
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polysaccharides
Polycaprolactone (PCL)
PLGA
Segmentation By Application
Drug Delivery
Orthopedics
Others
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the bioresorbable medical material market in 2025?
The bioresorbable medical material market benefits from increasing demand for minimally invasive surgical procedures and advancements in material science. These materials offer the advantage of eliminating the need for additional surgeries to remove implants, thus improving patient outcomes.
What are the weaknesses of the bioresorbable medical material market in 2025?
Challenges include high production costs and limited availability of specific materials. Additionally, there may be concerns regarding the mechanical properties and degradation rates of bioresorbable materials, which can impact their effectiveness in certain applications.
What opportunities exist for the bioresorbable medical material market in 2025?
There are significant opportunities in emerging markets and an increasing focus on personalized medicine. Innovations in technology and material development can lead to new applications, such as in drug delivery systems and tissue engineering.
What threats could affect the bioresorbable medical material market in 2025?
The market may face threats from regulatory challenges and the need for extensive clinical trials, which can delay product approvals. Additionally, competition from traditional materials and potential market saturation could impact growth.
Market PESTEL Analysis
What political factors influence the bioresorbable medical material market in 2025?
Government regulations and policies regarding medical devices and materials significantly impact the market. Support for innovation and research funding can drive advancements, while stringent regulatory requirements may pose challenges to market entry.
What economic factors affect the bioresorbable medical material market in 2025?
Economic growth in emerging markets and rising healthcare expenditures contribute to increased demand for advanced medical materials. However, economic downturns may lead to budget constraints in healthcare systems, affecting investment in new technologies.
What social factors are relevant to the bioresorbable medical material market in 2025?
There is a growing awareness of the benefits of minimally invasive procedures and biocompatible materials among patients and healthcare providers. Additionally, an aging population and rising chronic disease prevalence drive demand for innovative medical solutions.
What technological factors impact the bioresorbable medical material market in 2025?
Advancements in material science, such as improved polymer chemistry and fabrication techniques, enhance the performance of bioresorbable materials. Innovations in manufacturing processes also reduce costs and improve product availability.
What environmental factors should be considered in the bioresorbable medical material market in 2025?
Sustainability is increasingly important, with a focus on eco-friendly materials and processes. The market may benefit from the development of biodegradable options that minimize environmental impact, aligning with global sustainability goals.
What legal factors affect the bioresorbable medical material market in 2025?
Compliance with international standards and intellectual property rights is crucial for market players. Legal challenges related to patents and product liability can impact innovation and market dynamics, making it essential for companies to navigate these regulations effectively.
Market SIPOC Analysis
Who are the key suppliers in the bioresorbable medical material market in 2025?
Suppliers include raw material manufacturers, biotechnology firms, and chemical companies specializing in biopolymers and bioresorbable composites. Research institutions also play a role in developing advanced materials.
What are the main inputs in the bioresorbable medical material market in 2025?
Key inputs include biodegradable polymers, such as polylactic acid (PLA) and polyglycolic acid (PGA), as well as advanced processing technologies like 3D printing and nanotechnology. Regulatory approvals and clinical research data are also critical inputs.
What are the primary processes involved in the bioresorbable medical material market in 2025?
Processes include material synthesis, formulation, sterilization, and product development for applications like implants, sutures, and drug delivery systems. Extensive clinical testing and regulatory compliance processes ensure safety and efficacy.
Who are the key outputs in the bioresorbable medical material market in 2025?
Outputs include bioresorbable implants, surgical sutures, stents, and scaffolds used in tissue engineering. These materials degrade naturally in the body over time, eliminating the need for removal surgeries.
Who are the key customers in the bioresorbable medical material market in 2025?
Customers include hospitals, surgical centers, medical device manufacturers, and pharmaceutical companies. Additionally, healthcare providers and patients benefit from the improved treatment outcomes offered by these innovative materials.
Market Porter's Five Forces
How strong is the threat of new entrants in the bioresorbable medical material market in 2025?
The threat of new entrants is moderate due to high research and development costs, strict regulatory requirements, and the need for clinical validation. However, advancements in material science and increased funding for biotech startups could encourage new players.
How intense is the bargaining power of suppliers in the bioresorbable medical material market in 2025?
Suppliers of specialized biodegradable polymers and bioresorbable compounds hold significant bargaining power due to the limited availability of high-quality raw materials. Companies must establish strong supplier relationships to ensure material consistency and cost efficiency.
How significant is the bargaining power of buyers in the bioresorbable medical material market in 2025?
Buyers, including hospitals, medical device manufacturers, and pharmaceutical companies, have moderate to high bargaining power. They demand high-quality, cost-effective, and regulatory-compliant materials, pushing suppliers to innovate while maintaining competitive pricing.
How strong is the threat of substitutes in the bioresorbable medical material market in 2025?
The threat of substitutes is moderate, as traditional non-resorbable materials, such as titanium and stainless steel implants, remain widely used. However, growing preference for bioresorbable options due to their advantages in reducing secondary surgeries is shifting market dynamics.
How competitive is the rivalry among existing players in the bioresorbable medical material market in 2025?
The competition is high, with major biotech firms, pharmaceutical companies, and research institutions striving for innovation. Companies differentiate themselves through material advancements, regulatory approvals, and strategic collaborations to expand market share.
Market Upstream Analysis
Who are the key upstream suppliers in the bioresorbable medical material market in 2025?
Key upstream suppliers include chemical companies producing biodegradable polymers, biotechnology firms specializing in bioresorbable compounds, and research institutions developing advanced formulations.
What raw materials are essential for the bioresorbable medical material market in 2025?
Essential raw materials include polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), and other bioresorbable polymers. Additives, stabilizers, and nanomaterials are also used to enhance material properties.
What technological processes are involved in the upstream supply chain of the bioresorbable medical material market in 2025?
Processes include polymer synthesis, chemical modification, nanotechnology integration, and precision fabrication techniques like 3D printing and electrospinning. Advanced sterilization and quality control processes ensure material safety and consistency.
What challenges exist in the upstream supply chain of the bioresorbable medical material market in 2025?
Challenges include high production costs, limited availability of specialized raw materials, and stringent regulatory requirements for biocompatibility. Supply chain disruptions and geopolitical factors can also impact material sourcing.
How do upstream developments impact the overall bioresorbable medical material market in 2025?
Innovations in upstream materials directly influence product performance, safety, and adoption rates. Improvements in material synthesis and processing efficiency can lower costs, accelerate regulatory approvals, and expand clinical applications.
Market Midstream Analysis
Who are the key players in the midstream segment of the bioresorbable medical material market in 2025?
Key players include medical device manufacturers, contract research organizations (CROs), and biotech firms specializing in product development. These companies focus on transforming raw bioresorbable materials into functional medical devices.
What are the main processes involved in the midstream stage of the bioresorbable medical material market in 2025?
Processes include material formulation, device prototyping, precision manufacturing, sterilization, and regulatory testing. Advanced fabrication techniques like 3D printing and micro-molding enhance product quality and customization.
What quality control measures are critical in the midstream segment of the bioresorbable medical material market in 2025?
Strict quality control involves biocompatibility testing, degradation rate analysis, mechanical strength assessment, and compliance with medical regulations. Continuous monitoring ensures safety, efficacy, and consistency of the final products.
What challenges does the midstream segment face in the bioresorbable medical material market in 2025?
Challenges include balancing cost-effective production with high-quality standards, navigating complex regulatory approvals, and ensuring scalable manufacturing. Any material inconsistencies can affect product performance and patient safety.
How does the midstream segment impact the overall bioresorbable medical material market in 2025?
The midstream stage plays a crucial role in bridging material science with practical medical applications. Efficient manufacturing, strong regulatory compliance, and innovation in product design drive market growth and clinical adoption.
Market Downstream Analysis
Who are the key downstream players in the bioresorbable medical material market in 2025?
Key downstream players include hospitals, surgical centers, pharmaceutical companies, and healthcare providers who use bioresorbable materials in medical procedures and drug delivery systems.
What are the primary applications of bioresorbable medical materials in 2025?
These materials are widely used in surgical implants, orthopedic fixation devices, sutures, cardiovascular stents, and tissue engineering scaffolds. They help reduce the need for secondary surgeries and improve patient recovery.
How do end-users benefit from bioresorbable medical materials in 2025?
End-users benefit from reduced surgical complications, improved healing, and the elimination of implant removal procedures. Patients experience faster recovery, while healthcare providers see improved treatment efficiency.
What challenges exist in the downstream segment of the bioresorbable medical material market in 2025?
Challenges include high costs, limited awareness among healthcare professionals, and the need for extensive clinical validation to gain widespread adoption. Variability in material performance can also impact clinical outcomes.
How does the downstream segment influence the overall growth of the bioresorbable medical material market in 2025?
Market growth depends on successful adoption by healthcare facilities and patient acceptance. Increased awareness, favorable clinical outcomes, and regulatory support will drive demand and accelerate industry expansion.
Chapter 1, to describe Bioresorbable Medical Material product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bioresorbable Medical Material, with price, sales, revenue and global market share of Bioresorbable Medical Material from 2018 to 2023.
Chapter 3, the Bioresorbable Medical Material competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bioresorbable Medical Material breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Bioresorbable Medical Material market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bioresorbable Medical Material.
Chapter 14 and 15, to describe Bioresorbable Medical Material sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Bioresorbable Medical Material
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Bioresorbable Medical Material Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Polylactic Acid (PLA)
1.3.3 Polyglycolic Acid (PGA)
1.3.4 Polysaccharides
1.3.5 Polycaprolactone (PCL)
1.3.6 PLGA
1.4 Market Analysis by Application
1.4.1 Overview: Global Bioresorbable Medical Material Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Drug Delivery
1.4.3 Orthopedics
1.4.4 Others
1.5 Global Bioresorbable Medical Material Market Size & Forecast
1.5.1 Global Bioresorbable Medical Material Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Bioresorbable Medical Material Sales Quantity (2018-2029)
1.5.3 Global Bioresorbable Medical Material Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Evonik
2.1.1 Evonik Details
2.1.2 Evonik Major Business
2.1.3 Evonik Bioresorbable Medical Material Product and Services
2.1.4 Evonik Bioresorbable Medical Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Evonik Recent Developments/Updates
2.2 Corbion
2.2.1 Corbion Details
2.2.2 Corbion Major Business
2.2.3 Corbion Bioresorbable Medical Material Product and Services
2.2.4 Corbion Bioresorbable Medical Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Corbion Recent Developments/Updates
2.3 DSM
2.3.1 DSM Details
2.3.2 DSM Major Business
2.3.3 DSM Bioresorbable Medical Material Product and Services
2.3.4 DSM Bioresorbable Medical Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 DSM Recent Developments/Updates
2.4 Mitsui Chemicals
2.4.1 Mitsui Chemicals Details
2.4.2 Mitsui Chemicals Major Business
2.4.3 Mitsui Chemicals Bioresorbable Medical Material Product and Services
2.4.4 Mitsui Chemicals Bioresorbable Medical Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mitsui Chemicals Recent Developments/Updates
2.5 PCAS
2.5.1 PCAS Details
2.5.2 PCAS Major Business
2.5.3 PCAS Bioresorbable Medical Material Product and Services
2.5.4 PCAS Bioresorbable Medical Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 PCAS Recent Developments/Updates
2.6 Poly-Med
2.6.1 Poly-Med Details
2.6.2 Poly-Med Major Business
2.6.3 Poly-Med Bioresorbable Medical Material Product and Services
2.6.4 Poly-Med Bioresorbable Medical Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Poly-Med Recent Developments/Updates
2.7 KLS Martin
2.7.1 KLS Martin Details
2.7.2 KLS Martin Major Business
2.7.3 KLS Martin Bioresorbable Medical Material Product and Services
2.7.4 KLS Martin Bioresorbable Medical Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 KLS Martin Recent Developments/Updates
3 Competitive Environment: Bioresorbable Medical Material by Manufacturer
3.1 Global Bioresorbable Medical Material Sales Quantity by Manufacturer (2018-2023)
3.2 Global Bioresorbable Medical Material Revenue by Manufacturer (2018-2023)
3.3 Global Bioresorbable Medical Material Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Bioresorbable Medical Material by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Bioresorbable Medical Material Manufacturer Market Share in 2022
3.4.2 Top 6 Bioresorbable Medical Material Manufacturer Market Share in 2022
3.5 Bioresorbable Medical Material Market: Overall Company Footprint Analysis
3.5.1 Bioresorbable Medical Material Market: Region Footprint
3.5.2 Bioresorbable Medical Material Market: Company Product Type Footprint
3.5.3 Bioresorbable Medical Material Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Bioresorbable Medical Material Market Size by Region
4.1.1 Global Bioresorbable Medical Material Sales Quantity by Region (2018-2029)
4.1.2 Global Bioresorbable Medical Material Consumption Value by Region (2018-2029)
4.1.3 Global Bioresorbable Medical Material Average Price by Region (2018-2029)
4.2 North America Bioresorbable Medical Material Consumption Value (2018-2029)
4.3 Europe Bioresorbable Medical Material Consumption Value (2018-2029)
4.4 Asia-Pacific Bioresorbable Medical Material Consumption Value (2018-2029)
4.5 South America Bioresorbable Medical Material Consumption Value (2018-2029)
4.6 Middle East and Africa Bioresorbable Medical Material Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Bioresorbable Medical Material Sales Quantity by Type (2018-2029)
5.2 Global Bioresorbable Medical Material Consumption Value by Type (2018-2029)
5.3 Global Bioresorbable Medical Material Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Bioresorbable Medical Material Sales Quantity by Application (2018-2029)
6.2 Global Bioresorbable Medical Material Consumption Value by Application (2018-2029)
6.3 Global Bioresorbable Medical Material Average Price by Application (2018-2029)
7 North America
7.1 North America Bioresorbable Medical Material Sales Quantity by Type (2018-2029)
7.2 North America Bioresorbable Medical Material Sales Quantity by Application (2018-2029)
7.3 North America Bioresorbable Medical Material Market Size by Country
7.3.1 North America Bioresorbable Medical Material Sales Quantity by Country (2018-2029)
7.3.2 North America Bioresorbable Medical Material Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Bioresorbable Medical Material Sales Quantity by Type (2018-2029)
8.2 Europe Bioresorbable Medical Material Sales Quantity by Application (2018-2029)
8.3 Europe Bioresorbable Medical Material Market Size by Country
8.3.1 Europe Bioresorbable Medical Material Sales Quantity by Country (2018-2029)
8.3.2 Europe Bioresorbable Medical Material Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Bioresorbable Medical Material Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Bioresorbable Medical Material Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Bioresorbable Medical Material Market Size by Region
9.3.1 Asia-Pacific Bioresorbable Medical Material Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Bioresorbable Medical Material Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Bioresorbable Medical Material Sales Quantity by Type (2018-2029)
10.2 South America Bioresorbable Medical Material Sales Quantity by Application (2018-2029)
10.3 South America Bioresorbable Medical Material Market Size by Country
10.3.1 South America Bioresorbable Medical Material Sales Quantity by Country (2018-2029)
10.3.2 South America Bioresorbable Medical Material Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Bioresorbable Medical Material Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Bioresorbable Medical Material Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Bioresorbable Medical Material Market Size by Country
11.3.1 Middle East & Africa Bioresorbable Medical Material Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Bioresorbable Medical Material Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Bioresorbable Medical Material Market Drivers
12.2 Bioresorbable Medical Material Market Restraints
12.3 Bioresorbable Medical Material Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Bioresorbable Medical Material and Key Manufacturers
13.2 Manufacturing Costs Percentage of Bioresorbable Medical Material
13.3 Bioresorbable Medical Material Production Process
13.4 Bioresorbable Medical Material Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Bioresorbable Medical Material Typical Distributors
14.3 Bioresorbable Medical Material Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Bioresorbable Medical Material Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Bioresorbable Medical Material Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Evonik Basic Information, Manufacturing Base and Competitors
Table 4. Evonik Major Business
Table 5. Evonik Bioresorbable Medical Material Product and Services
Table 6. Evonik Bioresorbable Medical Material Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Evonik Recent Developments/Updates
Table 8. Corbion Basic Information, Manufacturing Base and Competitors
Table 9. Corbion Major Business
Table 10. Corbion Bioresorbable Medical Material Product and Services
Table 11. Corbion Bioresorbable Medical Material Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Corbion Recent Developments/Updates
Table 13. DSM Basic Information, Manufacturing Base and Competitors
Table 14. DSM Major Business
Table 15. DSM Bioresorbable Medical Material Product and Services
Table 16. DSM Bioresorbable Medical Material Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. DSM Recent Developments/Updates
Table 18. Mitsui Chemicals Basic Information, Manufacturing Base and Competitors
Table 19. Mitsui Chemicals Major Business
Table 20. Mitsui Chemicals Bioresorbable Medical Material Product and Services
Table 21. Mitsui Chemicals Bioresorbable Medical Material Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mitsui Chemicals Recent Developments/Updates
Table 23. PCAS Basic Information, Manufacturing Base and Competitors
Table 24. PCAS Major Business
Table 25. PCAS Bioresorbable Medical Material Product and Services
Table 26. PCAS Bioresorbable Medical Material Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. PCAS Recent Developments/Updates
Table 28. Poly-Med Basic Information, Manufacturing Base and Competitors
Table 29. Poly-Med Major Business
Table 30. Poly-Med Bioresorbable Medical Material Product and Services
Table 31. Poly-Med Bioresorbable Medical Material Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Poly-Med Recent Developments/Updates
Table 33. KLS Martin Basic Information, Manufacturing Base and Competitors
Table 34. KLS Martin Major Business
Table 35. KLS Martin Bioresorbable Medical Material Product and Services
Table 36. KLS Martin Bioresorbable Medical Material Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. KLS Martin Recent Developments/Updates
Table 38. Global Bioresorbable Medical Material Sales Quantity by Manufacturer (2018-2023) & (K MT)
Table 39. Global Bioresorbable Medical Material Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Bioresorbable Medical Material Average Price by Manufacturer (2018-2023) & (USD/MT)
Table 41. Market Position of Manufacturers in Bioresorbable Medical Material, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Bioresorbable Medical Material Production Site of Key Manufacturer
Table 43. Bioresorbable Medical Material Market: Company Product Type Footprint
Table 44. Bioresorbable Medical Material Market: Company Product Application Footprint
Table 45. Bioresorbable Medical Material New Market Entrants and Barriers to Market Entry
Table 46. Bioresorbable Medical Material Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Bioresorbable Medical Material Sales Quantity by Region (2018-2023) & (K MT)
Table 48. Global Bioresorbable Medical Material Sales Quantity by Region (2024-2029) & (K MT)
Table 49. Global Bioresorbable Medical Material Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Bioresorbable Medical Material Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Bioresorbable Medical Material Average Price by Region (2018-2023) & (USD/MT)
Table 52. Global Bioresorbable Medical Material Average Price by Region (2024-2029) & (USD/MT)
Table 53. Global Bioresorbable Medical Material Sales Quantity by Type (2018-2023) & (K MT)
Table 54. Global Bioresorbable Medical Material Sales Quantity by Type (2024-2029) & (K MT)
Table 55. Global Bioresorbable Medical Material Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Bioresorbable Medical Material Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Bioresorbable Medical Material Average Price by Type (2018-2023) & (USD/MT)
Table 58. Global Bioresorbable Medical Material Average Price by Type (2024-2029) & (USD/MT)
Table 59. Global Bioresorbable Medical Material Sales Quantity by Application (2018-2023) & (K MT)
Table 60. Global Bioresorbable Medical Material Sales Quantity by Application (2024-2029) & (K MT)
Table 61. Global Bioresorbable Medical Material Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Bioresorbable Medical Material Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Bioresorbable Medical Material Average Price by Application (2018-2023) & (USD/MT)
Table 64. Global Bioresorbable Medical Material Average Price by Application (2024-2029) & (USD/MT)
Table 65. North America Bioresorbable Medical Material Sales Quantity by Type (2018-2023) & (K MT)
Table 66. North America Bioresorbable Medical Material Sales Quantity by Type (2024-2029) & (K MT)
Table 67. North America Bioresorbable Medical Material Sales Quantity by Application (2018-2023) & (K MT)
Table 68. North America Bioresorbable Medical Material Sales Quantity by Application (2024-2029) & (K MT)
Table 69. North America Bioresorbable Medical Material Sales Quantity by Country (2018-2023) & (K MT)
Table 70. North America Bioresorbable Medical Material Sales Quantity by Country (2024-2029) & (K MT)
Table 71. North America Bioresorbable Medical Material Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Bioresorbable Medical Material Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Bioresorbable Medical Material Sales Quantity by Type (2018-2023) & (K MT)
Table 74. Europe Bioresorbable Medical Material Sales Quantity by Type (2024-2029) & (K MT)
Table 75. Europe Bioresorbable Medical Material Sales Quantity by Application (2018-2023) & (K MT)
Table 76. Europe Bioresorbable Medical Material Sales Quantity by Application (2024-2029) & (K MT)
Table 77. Europe Bioresorbable Medical Material Sales Quantity by Country (2018-2023) & (K MT)
Table 78. Europe Bioresorbable Medical Material Sales Quantity by Country (2024-2029) & (K MT)
Table 79. Europe Bioresorbable Medical Material Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Bioresorbable Medical Material Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Bioresorbable Medical Material Sales Quantity by Type (2018-2023) & (K MT)
Table 82. Asia-Pacific Bioresorbable Medical Material Sales Quantity by Type (2024-2029) & (K MT)
Table 83. Asia-Pacific Bioresorbable Medical Material Sales Quantity by Application (2018-2023) & (K MT)
Table 84. Asia-Pacific Bioresorbable Medical Material Sales Quantity by Application (2024-2029) & (K MT)
Table 85. Asia-Pacific Bioresorbable Medical Material Sales Quantity by Region (2018-2023) & (K MT)
Table 86. Asia-Pacific Bioresorbable Medical Material Sales Quantity by Region (2024-2029) & (K MT)
Table 87. Asia-Pacific Bioresorbable Medical Material Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Bioresorbable Medical Material Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Bioresorbable Medical Material Sales Quantity by Type (2018-2023) & (K MT)
Table 90. South America Bioresorbable Medical Material Sales Quantity by Type (2024-2029) & (K MT)
Table 91. South America Bioresorbable Medical Material Sales Quantity by Application (2018-2023) & (K MT)
Table 92. South America Bioresorbable Medical Material Sales Quantity by Application (2024-2029) & (K MT)
Table 93. South America Bioresorbable Medical Material Sales Quantity by Country (2018-2023) & (K MT)
Table 94. South America Bioresorbable Medical Material Sales Quantity by Country (2024-2029) & (K MT)
Table 95. South America Bioresorbable Medical Material Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Bioresorbable Medical Material Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Bioresorbable Medical Material Sales Quantity by Type (2018-2023) & (K MT)
Table 98. Middle East & Africa Bioresorbable Medical Material Sales Quantity by Type (2024-2029) & (K MT)
Table 99. Middle East & Africa Bioresorbable Medical Material Sales Quantity by Application (2018-2023) & (K MT)
Table 100. Middle East & Africa Bioresorbable Medical Material Sales Quantity by Application (2024-2029) & (K MT)
Table 101. Middle East & Africa Bioresorbable Medical Material Sales Quantity by Region (2018-2023) & (K MT)
Table 102. Middle East & Africa Bioresorbable Medical Material Sales Quantity by Region (2024-2029) & (K MT)
Table 103. Middle East & Africa Bioresorbable Medical Material Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Bioresorbable Medical Material Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Bioresorbable Medical Material Raw Material
Table 106. Key Manufacturers of Bioresorbable Medical Material Raw Materials
Table 107. Bioresorbable Medical Material Typical Distributors
Table 108. Bioresorbable Medical Material Typical Customers
List of Figures
Figure 1. Bioresorbable Medical Material Picture
Figure 2. Global Bioresorbable Medical Material Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Bioresorbable Medical Material Consumption Value Market Share by Type in 2022
Figure 4. Polylactic Acid (PLA) Examples
Figure 5. Polyglycolic Acid (PGA) Examples
Figure 6. Polysaccharides Examples
Figure 7. Polycaprolactone (PCL) Examples
Figure 8. PLGA Examples
Figure 9. Global Bioresorbable Medical Material Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Bioresorbable Medical Material Consumption Value Market Share by Application in 2022
Figure 11. Drug Delivery Examples
Figure 12. Orthopedics Examples
Figure 13. Others Examples
Figure 14. Global Bioresorbable Medical Material Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Bioresorbable Medical Material Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Bioresorbable Medical Material Sales Quantity (2018-2029) & (K MT)
Figure 17. Global Bioresorbable Medical Material Average Price (2018-2029) & (USD/MT)
Figure 18. Global Bioresorbable Medical Material Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Bioresorbable Medical Material Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Bioresorbable Medical Material by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Bioresorbable Medical Material Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Bioresorbable Medical Material Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Bioresorbable Medical Material Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Bioresorbable Medical Material Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Bioresorbable Medical Material Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Bioresorbable Medical Material Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Bioresorbable Medical Material Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Bioresorbable Medical Material Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Bioresorbable Medical Material Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Bioresorbable Medical Material Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Bioresorbable Medical Material Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Bioresorbable Medical Material Average Price by Type (2018-2029) & (USD/MT)
Figure 33. Global Bioresorbable Medical Material Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Bioresorbable Medical Material Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Bioresorbable Medical Material Average Price by Application (2018-2029) & (USD/MT)
Figure 36. North America Bioresorbable Medical Material Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Bioresorbable Medical Material Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Bioresorbable Medical Material Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Bioresorbable Medical Material Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Bioresorbable Medical Material Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Bioresorbable Medical Material Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Bioresorbable Medical Material Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Bioresorbable Medical Material Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Bioresorbable Medical Material Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Bioresorbable Medical Material Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Bioresorbable Medical Material Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Bioresorbable Medical Material Consumption Value Market Share by Region (2018-2029)
Figure 56. China Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Bioresorbable Medical Material Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Bioresorbable Medical Material Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Bioresorbable Medical Material Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Bioresorbable Medical Material Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Bioresorbable Medical Material Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Bioresorbable Medical Material Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Bioresorbable Medical Material Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Bioresorbable Medical Material Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Bioresorbable Medical Material Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Bioresorbable Medical Material Market Drivers
Figure 77. Bioresorbable Medical Material Market Restraints
Figure 78. Bioresorbable Medical Material Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Bioresorbable Medical Material in 2022
Figure 81. Manufacturing Process Analysis of Bioresorbable Medical Material
Figure 82. Bioresorbable Medical Material Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source